SetPoint has raised $140 million in private funding included $25 million in a second tranche of its Series C round and $115 million in its Series D financing led by Elevage Medical Technologies and Ally Bridge Group. The company said Josh Makower joined its board of directors as a representative of Elevage, and Kevin Reilly, managing director and head of medtech investments at Ally Bridge, also joined the board.

New investors Northwell Health, SPRIG Equity and an undisclosed strategic investor also participated in the Series D financing. Returning investors included Abbott, Boston Scientific and several others.